Innate anti-TNFα antibodies that neutralize TNFα are found in patients who are subsequent nonresponders to infliximab

被引：0
|
作者：
Ebert, Ellen C.
Das, Kiron M.
Mithani, Sima
机构：
来源：
GASTROENTEROLOGY | 2008年 / 134卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：A648 / A648
页数：1
相关论文
共 50 条
  • [41] Immunogenicity Analysis Of Two Anti-TNF (Infliximab vs Etanercept) Therapies In Rheumatologic Patients
    Barrios, Yvelise
    Matheu, Victor
    Franco, Andres
    Delgado, Esmeralda
    Bustabad, Sagrario
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2014, 133 (02) : AB185 - AB185
  • [42] Anti-TNF antibodies linked to malignancies and serious infections
    Reactions Weekly, 2006, 1084 (1) : 4 - 4
  • [43] Anti-TNF antibodies linked to malignancy/serious infection
    Reactions Weekly, 2006, 1104 (1) : 4 - 4
  • [44] Monitoring patients treated with anti-TNF- biopharmaceuticals: assessing serum infliximab and anti-infliximab antibodies
    Svenson, M.
    Geborek, P.
    Saxne, T.
    Bendtzen, K.
    RHEUMATOLOGY, 2007, 46 (12) : 1828 - 1834
  • [45] Antibodies to anti-TNF therapy—consequences for IBD management
    Welmoed K. van Deen
    Daniel W. Hommes
    Nature Reviews Gastroenterology & Hepatology, 2013, 10 : 446 - 448
  • [46] Early effects of anti-TNFα antibodies in horses with osteoarthritis
    Perrone, G.
    Giampaoli, C.
    Smirnoff, A. Lorenzo
    Ochoa, A.
    Pareja, R.
    De Simone, E.
    JOURNAL OF EQUINE VETERINARY SCIENCE, 2025, 147
  • [47] Anti-TNF trough levels and detection of antibodies to anti-TNF in inflammatory bowel disease: are they ready for everyday clinical use?
    Miheller, Pal
    Kiss, Lajos Sandor
    Lorinczy, Katalin
    Lakatos, Peter Laszlo
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2012, 12 (02) : 179 - 192
  • [48] ANTI-DRUG ANTIBODIES: ASSAY PERFORMANCE IN PATIENTS TREATED WITH ANTI-TNF BIODRUGS
    Hock, B.
    O'donnell, J. L.
    Liu, J.
    Keating, P.
    Spellerberg, M.
    Stamp, L.
    Barclay, M.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 1415 - 1415
  • [49] ANTI-DRUG ANTIBODIES AS A PREDICTOR FOR THE DISCONTINUATION OF ANTI-TNF AGENTS IN PATIENTS WITH SPONDYLOARTHRTIS
    Kim, H. J.
    Hwang, J.
    Kim, I.
    Jeong, H.
    Lee, J.
    Jeon, C. H.
    Koh, E. -M.
    Cha, H. -S.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 717 - 718
  • [50] Demyelination After Anti-TNF Therapy: Who is at Risk?
    Williams, Isabelle
    Uhlig, Holm H.
    JOURNAL OF CROHNS & COLITIS, 2020, 14 (12): : 1651 - 1652
12345